CombiGene: New issue registered

CombiGene AB realized a preference share issue in February 2018. The issue raised 2.3
million kronor before issuing expenses.

Read more >>

Share

News

December 2, 2024

CombiGene conducts Extraordinary General Meeting

November 14, 2024

Shareholders’ proposal for election of Board of Directors

November 8, 2024

Interim report January – September 2024 for CombiGene AB (publ)

November 1, 2024

NOTICE OF EXTRAORDINARY GENERAL MEETING IN COMBIGENE AB (PUBL)

October 31, 2024

The Board of Directors of CombiGene has received proposals from the Company’s largest shareholder for the Extraordinary General Meeting intended to be convened

October 28, 2024

CombiGene Initiates Measures to Extend Liquidity Horizon by Sharpening Strategic Focus on Gene Therapy, Prioritizing Pipeline Assets, and Implementing a Cost Reduction Program

September 30, 2024

CombiGene announces new preclinical research results in the epilepsy project

August 23, 2024

Interim report January – June 2024 for CombiGene AB (publ)

Load more